Every year 4,500 are diagnosed with the condition in the United Kingdom, with more than 3,600 death occurs as a result.
Even with treatment, the time average survival for people with brain cancer from 12 to 14 months, but experts believe the United States health care that they have found a solution to this.
At the moment, most treatments for brain cancer kind of aggressive malignant tumors and brain glioblastoma Multiforme (GBM), through radiation and chemotherapy and surgery.
Although this is usually effective in the short term, specializing in "Tufts University School of medicine", sakler graduate school Biomedical Sciences in Boston think they found a more specific treatment.
Experts believe the STAT3 gene in annex regulates cancer stem cells associated with the condition, but this could be the target of suppression of tumor growth.
Author Senior Professor Cochran Brent way more effective than treatment can extend the life of many owners of private health insurance.
"STAT3 has proven to be activated in a number of human tumours. According to this study first, however, that regulates cancer stem cells, STAT3.
As many current treatments specifically targeted cell, gene most patients remain strong resistance to treatment, he added.
"It's one of the few genes associated with cancer and stem cells published appears to regulate the processes involved six imprints: Cancer Metastasis, muscle, evade apoptosis and tissue invasion and cell imortalisishn," Dr. Cochran.
Now the Group hopes to draw new methods towards affordable medical insurance in an attempt to have an impact on brain cancer deaths 3,600 each year in the United Kingdom.
Take a look at affordable medical insurance [http://www.aigdirect.co.uk/health/] from AIG.
Tidak ada komentar:
Posting Komentar